Tranexamic Acid "Maxna" (by gul nawaz khan)
-
Upload
gul-nawaz -
Category
Health & Medicine
-
view
679 -
download
6
description
Transcript of Tranexamic Acid "Maxna" (by gul nawaz khan)
GNK 1
BLOODMENORRHAGIAHEMOSTASIS
MAXNA (The Product)
Blood is a specialized body fluid. Blood is the fluid pumped by the heart
that circulates throughout the body via the arteries, veins, and capillaries
Blood is a connective tissue. It provides communication between the cells of different part of the body and the external environment.
An adult male of average size normally has about 5.6 liters of blood
GNK 3
The blood carries oxygen and nutrients to the body tissues and removes carbon dioxide and other wastes
GNK 4
Fluid, known as Plasma.(55%)
Blood cells(45%), (Red cells, White cells, Platelets.)
GNK 5
GNK 6
GNK 7
GNK 8
GNK 9
GNK 10
Gases Nutrients Hormones Heat Productive substances Clotting material
GNK 11
Respiration Nutrition Removal of waste products Regulation Of Body Temperature Hormones transportion Defense of body
GNK 12
HEMOSTASISHEMOSTASIS PlateletPlatelet FibrinogenFibrinogen SerumSerum
IMMUNOLOGYIMMUNOLOGY LymphocytesLymphocytes PHAGOCYTOSISPHAGOCYTOSIS LuecocytesLuecocytes
GNK 13
Events in Hemostasis 1) vasoconstriction 2) platelet plug formation 3) blood clotting
GNK 14
GNK 15
1) Acitvation of plasminogen into plasmin2) Lysis of a clot or thrombus
GNK 16
1) Intrinsic – begins with activation of (Hagman) Factor XII
2) Extrinsic – starts with tissue injury and release of Tissue Factor (thromboplastin)
GNK 17
I.I. FibrinogenFibrinogenII.II. ProthrombinProthrombinIII.III. ThromboplastinThromboplastinIV.IV. Ca++Ca++V.V. Labile factorLabile factorVI.VI. Number no Number no
longer usedlonger usedVII.VII. Stable factorStable factor
viii.viii. Antihaemophilic Antihaemophilic factorfactor
ix.ix. Christmas factorChristmas factorx.x. Stuart-prower Stuart-prower
fcatorfcatorxi.xi. PTAPTAxii.xii. Hagman factorHagman factorxiii.xiii. Fibrin Fibrin
stabilizing stabilizing factorfactor
GNK 18
BLOOD CLOT
GNK 19
1) Menstruation at regular cyclic intervals but with excessive flow and duration
2) Total blood loss exceeding 80ml per cycle or menses lasting longer than 7 days
GNK 20
Organic causes 1)Infections= STDs 2)PIDs
Coagulation disorders Hepatic failure
GNK 21
Hypothyriodism Hyperthyriodism Anovulatory cycles
GNK 22
Uterine fibroids Endometrial hyperplasia
GNK 23
IUDs Steriod hormones Anticoagulatns PG E Progesterone
GNK 24
A)Drug treatment 1)NSAIDs (20-24%) 2)Antifibrinolytics (Tranexamic acid
58%) B)Hormones (progesterone30%)
(COCP 43%) C)Surgical options(D&C)
(Hysterectomy)
GNK 25
Synthetic amino acid Tranexamic acid Antiplasminic Absorption 30-50% (oral) PHL ~1.4h Excreted unchanged through kidney
GNK 26
Maxna inhibits conversion of plasminogen to plasmin by blocking the lysine binding sites of plasminogen, hence prevents breakdown of clot.
GNK 27
Tissue ThromboplastinTissue Thromboplastin BloodBlood ThromboplastinThromboplastin
ProthrombinProthrombin
ThrombinThrombin
FibronogenFibronogen Fibrin or ClotFibrin or Clot
Tisse ActivitorTisse Activitor Blood ActivitorBlood Activitor
PLASMINOGENPLASMINOGEN
PLASMINPLASMIN
F.D.PF.D.P
PROTHROMBINPROTHROMBIN
FIBRINOGENFIBRINOGEN FIBRIN OR CLOTFIBRIN OR CLOT
TISSUE TTHROMBOPLASTINTISSUE TTHROMBOPLASTIN
THROMBINTHROMBIN
PLASMINOGENPLASMINOGEN
PLASMINPLASMIN
F.D.PF.D.P
BLOOD ACTIVITORBLOOD ACTIVITOR
BLOOD THROMBOPLASTINBLOOD THROMBOPLASTIN
TISSUE ACITVATORTISSUE ACITVATOR
COAGULATION & FIBRINOLYTIC SYSTEMCOAGULATION & FIBRINOLYTIC SYSTEMGNK 29
GNK 30
Lysine Binding Lysine Binding SiteSite
FIBRINFIBRIN
GNK 31
PlasminogenPlasminogentPAtPA
FibrinFibrin
Maxna blocks lysing-binding
site and prevents bleeding
GNK 32
To prevent blood loss in DUB IUd PPh APH During and after surgery. In trauma
GNK 33
Maxna capsulesMaxna capsules Moderate bleeding= 250-500mg 3-4
times daily Severe bleeding= 500-1000mg 3-4
times daily
InjectionInjection 250-500mg I.V or I.M 1-2 times daily.
GNK 34
Generally well tolerated May cause G.I. disorder, nausea,
vomiting, and headache after oral administration.
Increased risk of adverse thrombotic events
No increase risk of DVT.
GNK 35
Maxna capsules: 250mg *20’s Maxna capsules:500mg*20’s Maxna injection:500mg*10’s
GNK 36